Iricar® (Ointment, Cream) Instructions for Use
ATC Code
D04AX (Other antipruritic drugs)
Clinical-Pharmacological Group
Homeopathic preparation used for inflammatory skin diseases accompanied by itching
Pharmacotherapeutic Group
Homeopathic single-component agent
Pharmacological Action
The instructions for medical use were approved by the Pharmacological Committee of the Ministry of Health of the Russian Federation on 14.01.1999.
Homeopathic medicinal product for external use.
Indications
Used in the complex therapy of skin diseases accompanied by itching:
- Neurodermatitis;
- Atopic dermatitis;
- Eczema;
- Dermatitis and consequences of insect bites.
ICD codes
| ICD-10 code | Indication |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L23 | Allergic contact dermatitis |
| L24 | Irritant contact dermatitis |
| L28.0 | Lichen simplex chronicus (circumscribed neurodermatitis) |
| L29 | Pruritus |
| L30.0 | Nummular eczema |
| L30.9 | Dermatitis, unspecified |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| ICD-11 code | Indication |
| 9A06.70 | Atopic eczema of the eyelids |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EA83.00 | Lichen simplex of vulva |
| EA83.01 | Lichen simplex of male genital organs |
| EA83.02 | Lichen simplex of perianal area |
| EA83.0Z | Lichen simplex of unspecified location |
| EA85.20 | Atopic hand eczema |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EC90.Z | Itching, unspecified |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EK00.Z | Allergic contact dermatitis, unspecified |
| EK02.Z | Irritant contact dermatitis, unspecified |
| ND56.0 | Superficial injury of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Ointment
Adults and children over 1 year of age should apply Iricar® ointment to the affected areas of the skin in a thin layer, rubbing gently, 3 times a day.
If there is no therapeutic effect within 2 weeks, it is necessary to consult a doctor.
Cream
Adults and children over 1 year of age should apply the cream 3 times a day in a thin layer to the affected areas of the skin, rubbing gently.
Due to good tolerability, Iricar® cream can be used for a long time.
Adverse Reactions
In rare cases, allergic skin reactions to the ingredients of the cream base may be observed.
Contraindications
The medicinal product should not be used in case of hypersensitivity to the ingredients of the cream base, for example, to benzyl alcohol.
Pediatric Use
Children over one year of age should apply the cream 3 times a day in a thin layer to the affected areas of the skin.
Drug Interactions
None identified.
Storage Conditions
Store at a temperature not exceeding 25°C (77°F) and not below 0°C (32°F) in a place inaccessible to children.
Shelf Life
The shelf life is 3 years.
After opening the package, store for no more than 6 months.
The medicine should not be used after the expiration date indicated on the package.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Ointment for external use: tube 50 g
Marketing Authorization Holder
Deutsche Homoeopathie-Union DHU-Arzneimittel GmbH & Co. KG (Germany)
Dosage Form
 |
Iricar® | Ointment for external use: tube 50 g |
Dosage Form, Packaging, and Composition
Ointment for external use homogeneous, light yellow in color; slight release of light yellow oil in the area of the tube opening is possible, which is not a sign of instability and is safe.
| 10 g | |
| Matrix tincture of Cardiospermum halicacabum | 1 g |
Excipients: lanolin, lanolin-based alcohol ointment (from lanolin alcohols, white petrolatum, cetylstearyl alcohol), thick paraffin, purified water.
50 g – aluminum tubes (1) – cardboard packs.
Cream for external use: tube 50 g
Marketing Authorization Holder
Deutsche Homoeopathie Union-Arzneimittel GmbH & Co. KG (Germany)
Dosage Form
|
Iricar® | Cream for external use: tube 50 g |
Dosage Form, Packaging, and Composition
Cream for external use shiny, slightly yellowish, with a faint odor of benzaldehyde.
| 10 g | |
| Matrix tincture of Cardiospermum halicacabum | 1 g |
Excipients: self-emulsifying ethylene glycol mono- and distearate (dragil), isopropyl myristate, stearyl heptanoate (PLC-solid), liquid paraffin, cetyl alcohol, glycerol 85%, benzyl alcohol, potassium hydroxide, purified water.
50 g – aluminum tubes (1) – cardboard packs.
![Iricar® [Ointment, Cream] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Iricar® [Ointment, Cream] 2")